H.C. Wainwright Reiterates Neutral Rating on Crinetics (CRNX)

August 11, 2026 6:47 AM

H.C. Wainwright analyst Douglas Tsao reiterated a Neutral rating and $85.00 price target on Crinetics (NASDAQ: CRNX).The analyst commented: "Crinetics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found